Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients
- PMID: 2923580
- DOI: 10.1161/01.atv.9.2.237
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients
Abstract
Several studies have indicated that genetic polymorphism of apolipoprotein (apo) E is related to coronary artery disease (CAD). We therefore determined the apo E phenotype in 91 consecutive Finnish men with angiographically confirmed CAD. The apo E phenotype distribution differed significantly from that observed in the Finnish population (p less than 0.05). In the patient group, the frequency of the epsilon 4 allele was 0.324, which is 1.4-fold higher than in the normal Finnish population and twice as high as in other Caucasian populations. Serum lipoproteins and postheparin plasma lipase activities did not display any significant variation according to apo E phenotype. These studies confirm and extend, in a population with high epsilon 4 allele frequency, the previous data on the impact of the epsilon 4 allele on the risk of CAD and suggest that the high epsilon 4 allele frequency in the Finnish population may be one factor contributing to Finns' increased susceptibility to CAD.
Similar articles
-
Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.Atherosclerosis. 1995 Apr 7;114(1):83-91. doi: 10.1016/0021-9150(94)05469-y. Atherosclerosis. 1995. PMID: 7605379
-
Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study.Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):918-25. doi: 10.1161/01.atv.16.8.918. Arterioscler Thromb Vasc Biol. 1996. PMID: 8696954
-
Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.Arterioscler Thromb. 1992 Jan;12(1):58-69. doi: 10.1161/01.atv.12.1.58. Arterioscler Thromb. 1992. PMID: 1346250
-
Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis. 1988 Jan-Feb;8(1):1-21. doi: 10.1161/01.atv.8.1.1. Arteriosclerosis. 1988. PMID: 3277611 Review.
-
Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.Am J Epidemiol. 2002 Mar 15;155(6):487-95. doi: 10.1093/aje/155.6.487. Am J Epidemiol. 2002. PMID: 11882522 Review.
Cited by
-
Genetics and personalized medicine--a role in statin therapy?Curr Atheroscler Rep. 2014 Jan;16(1):384. doi: 10.1007/s11883-013-0384-y. Curr Atheroscler Rep. 2014. PMID: 24293347 Review.
-
Machine Learning Approach for Cardiovascular Risk and Coronary Artery Calcification Score.Biomed Res Int. 2022 Jun 23;2022:2632770. doi: 10.1155/2022/2632770. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2023 Dec 29;2023:9894325. doi: 10.1155/2023/9894325. PMID: 35782065 Free PMC article. Retracted.
-
Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls.PLoS One. 2014 Apr 22;9(4):e95463. doi: 10.1371/journal.pone.0095463. eCollection 2014. PLoS One. 2014. PMID: 24755673 Free PMC article.
-
Reduced memory in fat mass and obesity-associated allele carriers among older adults with cardiovascular disease.Psychogeriatrics. 2013 Mar;13(1):35-40. doi: 10.1111/j.1479-8301.2012.00424.x. Psychogeriatrics. 2013. PMID: 23551410 Free PMC article.
-
Apolipoprotein-E Gene Polymorphism and Lipid Composition among IUGR and AGA Neonates.J Pediatr Genet. 2021 Feb 11;11(3):179-184. doi: 10.1055/s-0040-1722212. eCollection 2022 Sep. J Pediatr Genet. 2021. PMID: 35990035 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous